Docoh
Loading...

IBM International Business Machines

Title of each classCapital stock, par value $.20 per share
Trading symbolIBM
Common Stock

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report: April 28, 2020

(Date of earliest event reported)

 

 

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

New York 1-2360 13-0871985
(State of Incorporation) (Commission File Number) (IRS employer Identification No.)

 

One New Orchard Road

 
Armonk, New York10504
(Address of principal executive offices)(Zip Code)

 

914-499-1900

(Registrants telephone number)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol(s) Name of each exchange
on which registered
Capital stock, par value $.20 per share IBM New York Stock Exchange
    Chicago Stock Exchange
2.750% Notes due 2020 IBM 20B New York Stock Exchange
1.875% Notes due 2020 IBM 20A New York Stock Exchange
0.500% Notes due 2021 IBM 21B New York Stock Exchange
2.625% Notes due 2022 IBM 22A New York Stock Exchange
1.250% Notes due 2023 IBM 23A New York Stock Exchange
0.375% Notes due 2023 IBM 23B New York Stock Exchange
1.125% Notes due 2024 IBM 24A New York Stock Exchange
2.875% Notes due 2025 IBM 25A New York Stock Exchange
0.950% Notes due 2025 IBM 25B New York Stock Exchange
0.875% Notes due 2025 IBM 25C New York Stock Exchange
0.300% Notes due 2026 IBM 26B New York Stock Exchange
1.250% Notes due 2027 IBM 27B New York Stock Exchange
0.300% Notes due 2028 IBM 28B New York Stock Exchange
1.750% Notes due 2028 IBM 28A New York Stock Exchange
1.500% Notes due 2029 IBM 29 New York Stock Exchange
1.750% Notes due 2031 IBM 31 New York Stock Exchange
0.650% Notes due 2032 IBM 32A New York Stock Exchange
1.200% Notes due 2040 IBM 40 New York Stock Exchange
7.00% Debentures due 2025 IBM 25 New York Stock Exchange
6.22% Debentures due 2027 IBM 27 New York Stock Exchange
6.50% Debentures due 2028 IBM 28 New York Stock Exchange
7.00% Debentures due 2045 IBM 45 New York Stock Exchange
7.125% Debentures due 2096 IBM 96 New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a)International Business Machines Corporation (IBM) held its Annual Meeting of Stockholders on April 28, 2020. Below are the final voting results. For more information on the following proposals, see IBM’s proxy statement dated March 9, 2020, the relevant portions of which are incorporated herein by reference.

 

(b)

 

Election of Directors for a Term of One Year:

 

DIRECTOR FOR AGAINST ABSTAIN BROKER
NON-VOTES
 
T. Buberl 530,782,766 8,117,612 4,804,891 153,800,195 
M.L. Eskew 446,058,649 92,955,130 4,690,278 153,800,195 
D.N. Farr 530,473,498 8,648,851 4,582,920 153,800,195 
A. Gorsky 523,652,566 15,535,449 4,517,254 153,800,195 
M. Howard 525,987,595 13,515,468 4,202,206 153,800,195 
A. Krishna 533,120,525 6,416,264 4,167,840 153,800,195 
A.N. Liveris 522,668,459 16,450,470 4,586,340 153,800,195 
F.W. McNabb III 531,009,455 8,126,074 4,569,740 153,800,195 
M.E. Pollack 530,452,947 9,084,298 4,168,024 153,800,195 
V.M. Rometty 519,955,616 19,570,612 4,178,401 153,800,195 
J.R. Swedish 517,792,267 21,159,302 4,753,700 153,800,195 
S.Taurel 507,961,310 31,113,268 4,630,691 153,800,195 
P.R. Voser 529,656,944 8,730,726 5,313,202 153,800,195 
F.H. Waddell 495,970,749 42,919,103 4,814,625 153,800,195 

 

Ratification of Appointment of Independent Registered Public Accounting Firm:

 

For 659,040,058 95.1%     
Against 34,131,805 4.9%     
Abstain 4,330,209       

 

Management Proposal on Advisory Vote on Executive Compensation (Say on Pay):

 

For 462,242,258 86.2%     
Against 73,801,698 13.8%     
Abstain 7,661,313       
Broker Non-Votes 153,800,195       

 

Stockholder Proposal on Shareholder Right to Remove Directors:

 

For 291,959,257 54.5%     
Against 244,150,360 45.5%     
Abstain 7,594,214       
Broker Non-Votes 153,800,195       

 

Stockholder Proposal on the Right to Act by Written Consent:

 

For 225,781,910 42.2%     
Against 308,775,250 57.8%     
Abstain 9,148,109       
Broker Non-Votes 153,800,195       

 

2

 

 

Stockholder Proposal to Have an Independent Board Chairman:

 

For 232,083,099 43.3%     
Against 303,957,150 56.7%     
Abstain 7,665,020       
Broker Non-Votes 153,800,195       

 

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Date:  April 29, 2020 
  
   
 By:/s/ Frank Sedlarcik
  Frank Sedlarcik
  Vice President, Assistant General Counsel and Secretary

 

4